Exploring new methods to modify proteins for better health treatments
Official title: Developing synthetic chemical biology strategies for biochemical investigations and biomedical applications
Funded at University of Nebraska Lincoln · NIH-10885908 · Data updated 2026-11-12
This study is exploring new ways to change proteins while they're being made to create better treatments for diseases caused by protein problems, which could help patients get more effective therapies.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Nebraska Lincoln NIH-funded |
| Lab location | 1 site (Lincoln, United States) |
| Project start | July 15, 2023 |
| Project end | June 30, 2028 |
| Funding year | 2024 |
| Award (this year) | $371,036 |
| NIH project number | 5R35GM149322-02 |
| Project ID | NIH-10885908 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals with diseases or conditions that involve protein dysfunction or require innovative therapeutic strategies.
✕Less likely to help
Patients with conditions unrelated to protein modifications or those who do not require advanced therapeutic interventions may not benefit from this research.
What this research studies
This research investigates how to modify proteins using innovative techniques to improve their function and develop new therapies for diseases. It focuses on co-translational modifications, which occur as proteins are being made, and aims to enhance the genetic code to allow for the incorporation of noncanonical amino acids. By reprogramming the genetic code, the researchers hope to create more effective therapeutic agents that can target various biological processes. Patients may benefit from advancements in treatments for conditions linked to protein dysfunction.
Why it matters
Potential benefit: If successful, this research could lead to the development of new therapeutic agents that improve treatment options for diseases related to protein modifications.
How similar studies have gone: Previous research has shown promise in the field of protein modifications and genetic code engineering, indicating potential for success in this innovative approach.
Where this research is happening
-
University of Nebraska Lincoln
Lincoln, United States Active
Researchers
- Principal investigator: Guo, Jiantao — University of Nebraska Lincoln
- Study coordinator: Guo, Jiantao
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.